Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction.

Bao Y, Rong W, Zhu A, Chen Y, Chen H, Hong Y, Le J, Wang Q, Naman CB, Xu Z, Liu L, Cui W, Wu X.

Open source

DOI
10.3390/pharmaceutics15092311
Published
2023-09-13
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics15092311,
  title = {Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction.},
  author = {Bao Y and  Rong W and  Zhu A and  Chen Y and  Chen H and  Hong Y and  Le J and  Wang Q and  Naman CB and  Xu Z and  Liu L and  Cui W and  Wu X.},
  year = {2023},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics15092311},
  url = {https://doi.org/10.3390/pharmaceutics15092311}
}

RIS

TY  - JOUR
TI  - Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction.
AU  - Bao Y
AU  -  Rong W
AU  -  Zhu A
AU  -  Chen Y
AU  -  Chen H
AU  -  Hong Y
AU  -  Le J
AU  -  Wang Q
AU  -  Naman CB
AU  -  Xu Z
AU  -  Liu L
AU  -  Cui W
AU  -  Wu X.
PY  - 2023
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics15092311
UR  - https://doi.org/10.3390/pharmaceutics15092311
ER  -

APA

Y, B., W, R., A, Z., Y, C., H, C., Y, H., J, L., Q, W., CB, N., Z, X., L, L., W, C., & X., W. (2023). Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15092311

Source records